FDA Adds Vision-Risk Warning to Weight-Loss Drugs

Published on Honduras Daily · Nov 14, 2026 · Originally reported November 13, 2026 by Once Noticias

US health authorities are updating safety labels on GLP-1 drugs used for diabetes and weight loss after finding 6.4 cases of optic neuropathy per 100,000 users in clinical trials, prompting doctors to warn against unsupervised use.

An auto-translated English version isn’t available for Once Noticias, so this opens the original in Spanish. Honduras Daily curates and summarizes; the reporting is theirs.

Related stories

The Honduras Report

Honduras, in English, in your inbox.

The week's most consequential stories on Honduras with the context behind them, every Thursday. Free.

Honduras, in English — one email every Thursday. Free, and unsubscribe anytime.